Hester Biosciences Limited
NSE: HESTERBIO BSE: HESTERBIO
NSE
1,548.10
-36.90 (-2.33%)
Prev Close
1585
Open Price
1586.5
Volume
5,137
Today Low / High
1540 / 1586.5
52 WK Low / High
1242.95 / 2350
Range
1,471 - 1,626
BSE
1,544.70
-32.15 (-2.04%)
Prev Close
1576.85
Open Price
1551
Volume
12
Today Low / High
1536.9 / 1573.1
52 WK Low / High
1246.75 / 2347.7
Range
1,467 - 1,622
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 1548.1 (target range: 1,471 - 1,626), reflecting a change of -36.9 (-2.32808%). On the BSE, it is listed at 1544.7 (target range: 1,467 - 1,622), showing a change of -32.15 (-2.03887%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
20 Feb
1,582.80
-0.66%
19 Feb
1,593.20
-1.34%
18 Feb
1,593.10
-0.70%
17 Feb
1,569.50
0.72%
16 Feb
1,569.00
0.10%
13 Feb
1,579.00
-0.91%
12 Feb
1,530.00
3.58%
11 Feb
1,539.60
-0.62%
10 Feb
1,516.10
2.06%
09 Feb
1,509.50
0.56%
06 Feb
1,546.80
-2.41%
05 Feb
1,521.00
-0.41%
04 Feb
1,515.00
0.82%
03 Feb
1,512.00
-0.55%
02 Feb
1,530.00
-1.91%
01 Feb
1,506.00
0.40%
30 Jan
1,460.00
1.63%
29 Jan
1,446.10
-0.43%
28 Jan
1,411.00
1.79%
Hester Biosciences Limited Graph
Hester Biosciences Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Hester Biosciences Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,548.10, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 1,544.70 | 1,560.15 | 1,404.13 - 1,716.16 |
| 1,575.59 | 1,260.48 - 1,890.71 | ||
| 1,591.04 | 1,113.73 - 2,068.35 | ||
| Bearish Scenario | 1,544.70 | 1,529.25 | 1,376.33 - 1,682.18 |
| 1,513.81 | 1,211.04 - 1,816.57 | ||
| 1,498.36 | 1,048.85 - 1,947.87 |
Overview of Hester Biosciences Limited
ISIN
INE782E01017
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
4,141
Market Cap
13,338,764,320
Last Dividend
7
Official Website
IPO Date
2015-03-13
DCF Diff
2,344.89
DCF
-845
Financial Ratios Every Investor Needs
Stock Dividend of HESTERBIO
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-08-06 | August 06, 25 | 7 | 7 | 2025-08-06 | 2025-09-12 | |
| 2024-08-22 | August 22, 24 | 6 | 6 | 2024-08-22 | 2024-09-28 | |
| 2023-09-13 | September 13, 23 | 8 | 8 | 2023-09-13 | 2023-09-25 | |
| 2022-08-11 | August 11, 22 | 10 | 10 | 2022-08-12 | 2022-09-22 | |
| 2021-08-05 | August 05, 21 | 10 | 10 | 2021-08-06 | 2021-09-16 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 311.10 Cr | 102.63 Cr | 208.47 Cr | 0.6701 | 5.95 Cr | 65.08 Cr | 45.51 Cr | 27.49 Cr | 32.31 | 64.98 Cr | 0.0884 |
| 2024-03-31 | 304.55 Cr | 207.28 Cr | 97.26 Cr | 0.3194 | 4.67 Cr | 4.90 Cr | 36.48 Cr | 18.89 Cr | 22.20 | 58.25 Cr | 0.0620 |
| 2023-03-31 | 266.09 Cr | 77.49 Cr | 188.61 Cr | 0.7088 | 3.39 Cr | 5.32 Cr | 31.03 Cr | 26.63 Cr | 31.30 | 61.92 Cr | 0.1001 |
| 2022-03-31 | 235.01 Cr | 68.86 Cr | 166.15 Cr | 0.7070 | 0.00 Cr | 7.42 Cr | 125.24 Cr | 39.32 Cr | 46.22 | 73.19 Cr | 0.1673 |
| 2021-03-31 | 214.33 Cr | 56.39 Cr | 157.94 Cr | 0.7369 | 1.02 Cr | 5.96 Cr | 56.78 Cr | 34.43 Cr | 40.47 | 70.02 Cr | 0.1606 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 5.97 Cr | 653.39 Cr | 326.73 Cr | 314.2550 Cr | 213.25 Cr | 206.03 Cr | 70.38 Cr | 409.35 Cr | 0.00 Cr | 53.22 Cr | 35.67 Cr | 125.1840 Cr |
| 2024-03-31 | 12.75 Cr | 662.35 Cr | 359.47 Cr | 291.7930 Cr | 244.38 Cr | 232.07 Cr | 75.58 Cr | 407.58 Cr | 0.00 Cr | 53.67 Cr | 30.66 Cr | 105.7850 Cr |
| 2023-03-31 | 4.30 Cr | 669.97 Cr | 381.42 Cr | 279.7300 Cr | 274.15 Cr | 160.02 Cr | 84.81 Cr | 253.98 Cr | 16.87 Cr | 32.25 Cr | 26.73 Cr | 148.6960 Cr |
| 2022-03-31 | 24.27 Cr | 562.16 Cr | 294.77 Cr | 259.9850 Cr | 228.17 Cr | 203.90 Cr | 75.38 Cr | 337.39 Cr | 17.12 Cr | 19.71 Cr | 24.10 Cr | 96.8980 Cr |
| 2021-03-31 | 20.81 Cr | 411.05 Cr | 175.09 Cr | 228.3090 Cr | 109.70 Cr | 88.89 Cr | 62.22 Cr | 244.28 Cr | 8.97 Cr | 18.12 Cr | 2.80 Cr | 61.3660 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 64.5110 Cr | -19.0030 Cr | -51.7170 Cr | 43.9200 Cr | -6.7830 Cr | 5.5870 Cr | -20.5910 Cr | 27.4880 Cr | -33.1160 Cr | -5.1680 Cr | 5.2040 Cr |
| 2024-03-31 | 48.1340 Cr | -22.6540 Cr | -26.0450 Cr | 23.7370 Cr | -0.4080 Cr | 12.7480 Cr | -24.3970 Cr | 18.8890 Cr | -29.9990 Cr | -6.8050 Cr | 9.2290 Cr |
| 2023-03-31 | 23.5960 Cr | -76.9990 Cr | 41.7580 Cr | -54.1660 Cr | -11.5940 Cr | 13.1560 Cr | -77.7620 Cr | 40.1540 Cr | 38.9200 Cr | -8.5070 Cr | -9.4280 Cr |
| 2022-03-31 | 8.8080 Cr | -116.5880 Cr | 111.6100 Cr | -86.9020 Cr | 3.4810 Cr | 24.7500 Cr | -95.7100 Cr | 53.5020 Cr | 116.8690 Cr | -8.5070 Cr | -13.1600 Cr |
| 2021-03-31 | 58.0530 Cr | -38.3720 Cr | -18.2190 Cr | 17.3110 Cr | -2.2620 Cr | 21.2690 Cr | -40.7420 Cr | 50.1030 Cr | -22.8970 Cr | -5.6150 Cr | 1.7460 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 77.42 Cr | 40.68 Cr | 36.74 Cr | 0.4746 | 13.36 Cr | 8.77 Cr | 10.30 | 18.46 Cr | 0.1132 |
| 2025-09-30 | 70.97 Cr | 19.32 Cr | 51.65 Cr | 0.7278 | 7.36 Cr | 14.45 Cr | 16.85 | 23.60 Cr | 0.2036 |
| 2025-06-30 | 84.11 Cr | 22.46 Cr | 61.64 Cr | 0.7329 | 18.63 Cr | 16.44 Cr | 20.33 | 26.18 Cr | 0.1955 |
| 2025-03-31 | 81.93 Cr | 35.05 Cr | 42.82 Cr | 0.5226 | 16.26 Cr | 1.29 Cr | 1.82 | 12.26 Cr | 0.0158 |
| 2024-12-31 | 63.22 Cr | 19.63 Cr | 43.59 Cr | 0.6896 | 0.77 Cr | 11.66 Cr | 13.41 | 5.06 Cr | 0.1845 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 6.29 Cr | 21.87 Cr | 28.16 Cr | 93.14 Cr | 65.87 Cr | 203.72 Cr | 421.70 Cr | 675.18 Cr | 324.15 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 7.22 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -326.66 Cr |
| 2025-03-31 | 7.22 Cr | 0.00 Cr | 7.22 Cr | 73.18 Cr | 70.38 Cr | 195.17 Cr | 409.35 Cr | 653.39 Cr | 326.73 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 16.79 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -314.25 Cr |
| 2024-09-30 | 13.56 Cr | 3.23 Cr | 16.79 Cr | 99.91 Cr | 67.20 Cr | 222.19 Cr | 405.64 Cr | 669.25 Cr | 355.00 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 16.44 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 1.29 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 11.66 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 8.20 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 6.34 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,731.80 | ₹4,155,168,301,046.00 | ₹2,769,336.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,255.50 | ₹1,660,638,702,190.00 | ₹92,138.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹4,397.90 | ₹1,488,449,200,576.00 | ₹846,302.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,300.20 | ₹1,082,505,160,638.00 | ₹1,802,879.00 |
| Lupin Limited | LUPIN | ₹2,250.20 | ₹1,028,438,158,600.00 | ₹1,065,762.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹903.85 | ₹909,484,591,862.00 | ₹368,888.00 |
| Mankind Pharma Limited | MANKIND | ₹2,054.70 | ₹848,190,581,438.00 | ₹217,516.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,164.40 | ₹676,285,409,821.00 | ₹987,804.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,495.50 | ₹657,069,457,500.00 | ₹119,453.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,058.60 | ₹580,938,585,407.00 | ₹372,421.00 |
| Laurus Labs Limited | LAURUSLABS | ₹1,028.50 | ₹555,242,494,587.00 | ₹1,411,584.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,515.30 | ₹384,438,001,535.00 | ₹150,378.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,948.80 | ₹368,410,168,051.00 | ₹55,209.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹2,070.40 | ₹332,356,231,238.00 | ₹674,051.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,434.50 | ₹271,941,808,630.00 | ₹126,588.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,362.00 | ₹221,314,334,178.00 | ₹244,316.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,800.50 | ₹220,012,500,000.00 | ₹5,234.00 |
| Eris Lifesciences Limited | ERIS | ₹1,384.60 | ₹188,605,907,279.00 | ₹127,178.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,366.00 | ₹171,484,296,374.00 | ₹45,522.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹944.85 | ₹169,231,960,670.00 | ₹10,306,610.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹750.85 | ₹147,589,421,655.00 | ₹66,813.00 |
| Granules India Limited | GRANULES | ₹599.60 | ₹145,504,162,114.00 | ₹532,194.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹879.00 | ₹139,207,008,492.00 | ₹173,438.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,712.60 | ₹130,177,630,570.00 | ₹59,587.00 |
| Cohance Lifesciences Limited | COHANCE | ₹309.55 | ₹118,423,658,187.00 | ₹803,652.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹883.60 | ₹108,449,529,600.00 | ₹60,419.00 |
| Viyash Scientific Limited | VIYASH | ₹219.42 | ₹95,712,223,756.00 | ₹660,093.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,161.00 | ₹85,669,410,502.00 | ₹15,824.00 |
| Strides Pharma Science Limited | STAR | ₹861.00 | ₹79,360,706,754.00 | ₹126,250.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹483.70 | ₹74,055,465,455.00 | ₹170,943.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹320.55 | ₹62,693,751,119.00 | ₹180,158.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹690.90 | ₹62,628,212,661.00 | ₹146,064.00 |
| FDC Limited | FDC | ₹368.85 | ₹60,052,499,483.00 | ₹76,713.00 |
| Sequent Scientific Limited | SEQUENT | ₹202.40 | ₹50,564,340,966.00 | ₹13,647.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹127.50 | ₹41,376,502,470.00 | ₹473,000.00 |
| Innova Captab Limited | INNOVACAP | ₹671.80 | ₹38,443,707,302.00 | ₹18,427.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹319.30 | ₹34,792,609,115.00 | ₹45,187.00 |
| Suven Life Sciences Limited | SUVEN | ₹148.96 | ₹33,884,527,040.00 | ₹164,413.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹369.50 | ₹33,724,265,000.00 | ₹71,369.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹647.90 | ₹32,860,908,130.00 | ₹51,609.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹1,882.30 | ₹31,131,387,935.00 | ₹7,493.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹281.10 | ₹28,189,412,437.00 | ₹74,640.00 |
Key Executives
Chief Financial Officer
Ashish Dineshbhai Desai
Gender: male
Year Born: 1968
Chief Financial Officer
Divyesh Maru
Gender: male
Year Born:
Executive Chief Executive Officer, MD & Executive Director
Rajiv Dinesh Gandhi
Gender: male
Year Born: 1962
Company Secretary & Compliance Officer
Vinod Mali
Gender: male
Year Born:
Executive Director
Priya Gandhi
Gender: female
Year Born: 1993
Chief Executive Officer of Hester Biosciences Nepal Private Limited
Sulochana Shrestha
Gender: Not Specified
Year Born:
Consultant
Upendra K. Jani
Gender: Not Specified
Year Born: 1956
FAQs about Hester Biosciences Limited
Who is the CEO of the company?
The CEO is Rajiv Dinesh Gandhi.
What is the current market price of the stock?
The current price is ₹1,568.00.
What is the 52-week price range?
The range is ₹1242.95-2350.
What is the market capitalization of the company?
The market capitalization is ₹1,333.88 crores.
What is the dividend yield?
The dividend yield is 0.45%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 32.58.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Hester Biosciences Limited (ISIN: INE782E01017) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹1,333.88 crores and an average daily volume of 4,141 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹7.